Kappa Bioscience has announced the acquisition of PPM Ingredients, its long-term European distributor.
By integrating a sales function, Kappa said that it will increase its overall competitiveness with the ability to work more closely with customers and partners. PPM supplies more than 100 different grades of four distinct ingredients: vitamin K2, calcium, magnesium and vitamin D3. Its vitamin K2 portfolio is marketed under the brand name K2Vital.
The acquisition will instantly expand Kappa’s product line and increase its in-house expertise in bone and heart health.
It follows an acquisition last year for Synthetica – another long-term partner specializing in drug and vitamin synthesis, analysis, and research.
Together, the acquisitions provide Kappa with full ownership of its value chain, from development through to production and finished formulations. The two acquisitions also give Kappa the ability to develop and serve the wider ingredients marketplace.
Kappa Bioscience CEO Egil Greve said: “This is a very important acquisition for Kappa Bioscience because we are the first company in our industry to create an end-to-end solution, from molecule development and production via R&D to finished formulation or dosage format. The highly experienced and well-respected team at PPM will be a huge asset, not just in terms of continued market expansion, but also in the knowledge of vitamin K2 and how our customers can develop the category and promote the very important health benefits of K2.
“Though we are already the market leader, this increases our competitiveness and will help us fulfill our vision of bringing K2 to every consumer segment in every market channel.”
PPM Ingredients’ Jörg Büttinghaus added: ‘’We are very pleased to join the leading producer of vitamin K2 and, by doing so expand, the Kappa product line and Kappa’s ability to innovate customer solutions. We are equally excited to join a company with deep R&D experience and analytical services capabilities as this further expands how we can work with customers and partners.
“The K2 market is doubling in size each year, but is still relatively small. We see Kappa as the company with the scope and resources push K2 to the tipping point where we would see a development trajectory similar to what the market has seen with vitamin D3.”
PPM Ingredients will be continued under the name of Kappa Ingredients.
© FoodBev Media Ltd 2017